Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia
- PMID: 16127088
- PMCID: PMC1195400
- DOI: 10.1128/AAC.49.9.3980-3981.2005
Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia
Comment on
-
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.Antimicrob Agents Chemother. 2005 Feb;49(2):760-6. doi: 10.1128/AAC.49.2.760-766.2005. Antimicrob Agents Chemother. 2005. PMID: 15673761 Free PMC article.
References
-
- Lai, C. H., C. Y. Chi, H. P. Chen, et al. 2004. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J. Microbiol. Immunol. Infect. 37:350-358. - PubMed
-
- Micozzi, A., M. Venditti, M. Monaco, A. Friedrich, F. Taglietti, S. Santilli, and P. Martino. 2000. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin. Infect. Dis. 31:705-711. - PubMed
-
- Senol, E., J. DesJardin, P. C. Stark, L. Barefoot, and D. R. Snydman. 2002. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin. Infect. Dis. 34:1653-1656. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical